Shares of Bristol-Myers Squibb Rise to a New 52-Week High Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb (NYSE:BMY) is currently priced 2.8% above ... More Upside for Bristol-Myers Squibb ? |
